Egilok - analogues of the drug in terms of action and composition, what makes Egilok different from Egilok S

Egilok belongs to the group of cardioselective beta-blockers. The drug has antiarrhythmic, antianginal and antihypertensive effects.

Its main active ingredient is metoprolol tartrate in an amount of 25, 50 or 100 mg per 1 tablet.

Indications for admission may include the following diseases:

• ischemic heart disease (CHD);
• arterial hypertension;
• prevention of migraine attacks;
• cardiac disorders in combination with tachycardia;
• heart rhythm disruptions;
• with hyperthyroidism, it is part of complex therapy.

Egilok and analogues of the drug are often used to relieve attacks of tachycardia and atrial fibrillation. Due to its properties, the drug significantly reduces the heart rate (HR) to the level of sinus rhythm. Causes a persistent hypotensive effect towards the end 2nd weeks of admission.

The drug has high bioavailability. However, it can increase by almost half (by 30-40%), if taken during a meal. The maximum volume in blood plasma is reached within 1.5-2 hours.

Under the influence of the main element, the excessive activity of the sympathetic system in relation to the heart is suppressed. As a result, regular, and in some cases - long-term use of this medication helps to lower cholesterol levels.

According to the instructions, the medication should not be used during pregnancy and lactation. Of course, this is possible, but only in the II and III trimesters in situations where the potential benefit outweighs the expected harm to the fetus. If the drug is still prescribed, then you should continuously and carefully monitor the course of pregnancy, because the baby may have bradycardia, hypoglycemia, arterial hypotension and depressed breathing.

During lactation, taking Egilok (drug analogues) is extremely undesirablen - at the time of using the drug, experts advise to stop breastfeeding. In addition, due to insufficient data, it is categorically not recommended to take the drug to children under 18 years of age.

Also, a contraindication for taking the medication by adults is sinus bradycardia, sick sinus syndrome (SSS), severe stages of bronchial asthma and peripheral circulatory disorders, sinoatrial and atrioventricular block II and III degree, heart failure, hypersensitivity to components drug.

According to the Anatomical Therapeutic Chemical (ATC) Egilok, the analogs of the drug have the following composition:

• Betalok;
• Vasokardin;
• Metoprolol;
• Corvitol;
• Cardolax;
• Egilok Retard.

Egilok's list of analogues in action is much wider.

Among them there are both well-known and proven drugs, as well as modern III generation beta1-blockers with vasodilating (vasodilating) properties:

• Atenolol;
• Betakor;
• Bisoprolol;
• Concor;
• Lokren;
• Niperten;
• Nebilet;
• Nevotenz;
• Cordinorm;
• Cardiostad;
• Sotalol;
• Anaprilin.

What is the difference between Egilok and Egilok S and how it can be replaced

Egilok S also belongs to the class of beta1-blockers related to cardioselective drugs. It has no internal membrane stabilizing and sympathomimetic activity. This means that the drug is able to block beta1-adrenergic receptors, but does not stimulate them.

To the question "how does Egilok differ from Egilok S", one can answer that the latter has a longer period of action. In blood plasma, its concentration is constantly observed, which gives a stable clinical effect, reaching a duration of more than a day. Due to the fact that significant Cmax in blood plasma are absent, in comparison with conventional tablet forms containing metoprolol, it has a greater β1-selectivity.

The enumeration of the differences between Egilok and Egilok S does not end there. The second option has a much lower risk of side effects. In addition, each of its tablets contains many pellets (microgranules) that release the element metoprolol succinate. When the tablet enters the gastrointestinal tract, it breaks down into individual pellets. They function as independent particles and guarantee a controlled release of the main substance for 20 hours or more. The speed of this process is due to the acidity of the environment.

One more point can be noted in resolving the issue, how does Egilok differ from Egilok S.

The difference lies in the dosage - conventional tablets are taken, as a rule, 2 times a day, dividing the dose into morning and evening. And the long-acting drug is enough to use once a day, preferably in the morning. Dragee is swallowed without crushing, and washed down with water.

One more point: Egilok requires storage at a temperature of 15-25 degrees, Egilok C can withstand temperatures up to 30 degrees.

Overdose symptoms for both drugs are identical: slowing of the pulse (bradycardia), heart failure, decreased blood pressure, increased sweating, tremors (tremors of the limbs), hallucinations, nausea, vomit.

When deciding what to replace Egilok with, various options can be considered. However, the final decision on this issue should be made only by the doctor after a complete examination of the patient.

The same applies to those cases when there is a problem of joint medication intake. If, for example, a patient is interested in whether it is possible to take Nifecard and Egilok, then the relevance of such a scheme can be determined by a specialist only during an in-person visit.

At the same time, it is not always possible to choose the right option the first time - a health worker can go through several systems before finding the only one correct for a particular patient.

Judging by the reviews, experts are often asked the question: Metoprolol or Egilok - which is better? In fact, these are synonyms - Egilok is metoprolol.

• Anaprilin (producing countries - Russia, Ukraine, Latvia). This drug has been on the pharmaceutical market for a long time - it belongs to the first generation of beta-blockers. Now many doctors have abandoned its use due to the short period of action. Anaprilin is good in emergency cases - to block an attack of tachycardia, hypertension or panic attack. However, it is not suitable for systemic therapy.
• Concor (produced in Germany). When making a choice than to replace Egilok, doctors often recommend the drug Concor. It has fewer side effects and is milder. It should be borne in mind that with a sharp cancellation of Egilok's reception, the consequences can be the most tragic, up to and including death. But due to the fact that the drug is quickly addictive, after a certain period of time it ceases to produce the desired effect. There is a need for a gradual transition to a new drug. Concor is perfect in this case. Its effectiveness is much higher: for comparison - 50 mg of Egilok = 5 mg of Concor. Thanks to this, the load on the organs is reduced, so the body can more easily tolerate treatment. In addition, the duration of action of the new drug is doubled. The only drawback of Concor is the higher price.
• Bisoprolol (manufacturers - Germany, Ukraine, Russia, Israel). Egilok and Bisoprolol are identical drugs, so it is quite acceptable to replace one drug with another. However, the second agent is more interesting in the sense that it retains its hypotensive properties the next morning after taking the pill, and its analogs do not have a similar effect. As a rule, they partially or completely stop lowering blood pressure in a few hours (usually 3-4) until the next dose of the drug is taken.
• Atenolol (producing countries - India, Russia, Denmark).

Those who wish to change the drug and choose how to replace Egilok should know that, in comparison with it, Atenolol is a cheaper, but also less effective drug. Its daily requirement ranges from 100 to 250 mg. Because of this, there is an increased load on the body.

And in financial terms, such a purchase is unprofitable due to the large number of tablets used per day. Conclusion: it is worth purchasing it if the pharmacy does not have more effective medicines. Despite the possible identity of some drugs, you should definitely consult your doctor before changing the tablets.